Holen Sie sich die Stockscreener-App
4.11
7.22%
-0.32
Schlusskurs vom Vortag:
$4.43
Offen:
$4.64
24-Stunden-Volumen:
498.58K
Relative Volume:
0.65
Marktkapitalisierung:
$288.57M
Einnahmen:
$299.48M
Nettoeinkommen (Verlust:
$-86.45M
KGV:
-2.74
EPS:
-1.5
Netto-Cashflow:
$-17.32M
1W Leistung:
-7.22%
1M Leistung:
-25.95%
6M Leistung:
-51.30%
1J Leistung:
-49.51%
1-Tages-Spanne:
$4.10
$4.64
1-Wochen-Bereich:
$3.845
$4.64
52-Wochen-Spanne:
$3.7601
$9.24
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Vergleichen Sie HCAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
4.11 | 288.57M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
227.80 | 36.98B | 2.75B | 714.14M | 1.09B | 4.33 |
|
SOLV
Solventum Corp
|
72.30 | 12.51B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
60.80 | 11.41B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
93.97 | 8.14B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
42.16 | 7.26B | 640.44M | -743.28M | -206.93M | -11.29 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
Health Catalyst Expands Buyback With $5 Mln Share Repurchase - Nasdaq
Health Catalyst to buy back shares worth about $5 mln -March 11, 2025 at 10:37 am EDT - Marketscreener.com
Health Catalyst buys back $5 million in stock By Investing.com - Investing.com South Africa
Health Catalyst Announces ~$5 Million Stock Repurchase - PR Newswire
Health Catalyst general counsel Landry Benjamin sells $62,860 in stock By Investing.com - Investing.com Canada
Health Catalyst general counsel Landry sells shares worth $62,860 - Investing.com
Health Catalyst general counsel Landry sells shares worth $62,860 By Investing.com - Investing.com Canada
Health Catalyst COO Daniel LeSueur sells $76,331 in stock By Investing.com - Investing.com South Africa
Health Catalyst general counsel Landry Benjamin sells $62,860 in stock - Investing.com
Health Catalyst COO Daniel LeSueur sells $76,331 in stock - Investing.com India
Take Care Before Jumping Onto Health Catalyst, Inc. (NASDAQ:HCAT) Even Though It's 27% Cheaper - Simply Wall St
Stephens Issues Pessimistic Forecast for Health Catalyst (NASDAQ:HCAT) Stock Price - Defense World
10 Analysts Have This To Say About Health Catalyst - Benzinga
Health Catalyst Inc Reports Q4 2024 Earnings: EPS of -$0.33 Miss - GuruFocus.com
Health Catalyst Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Health Catalyst Acquires Upfront Healthcare in a $86 Million Deal to Strengthen Patient Engagement - Elets
Royal Bank of Canada Cuts Health Catalyst (NASDAQ:HCAT) Price Target to $6.00 - Defense World
Impax Asset Management Group plc Buys 195,525 Shares of Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Health Catalyst (NASDAQ:HCAT) Price Target Cut to $6.00 by Analysts at Royal Bank of Canada - MarketBeat
Stifel Nicolaus Has Lowered Expectations for Health Catalyst (NASDAQ:HCAT) Stock Price - MarketBeat
Health Catalyst to Seek Acquisition Opportunities -February 26, 2025 at 05:00 pm EST - Marketscreener.com
Health Catalyst (NASDAQ:HCAT) Earns Equal Weight Rating from Stephens - MarketBeat
Signature Healthcare selects Ignite ecosystem to improve analytic capabilities - Yahoo Finance
Health Catalyst’s Earnings Call Highlights Robust Growth and Strategic Challenges - TipRanks
Health Catalyst stock target cut to $10 at BTIG, retains Buy rating - Investing.com Canada
Health Catalyst (NASDAQ:HCAT) Issues Quarterly Earnings Results - MarketBeat
Compared to Estimates, Health Catalyst (HCAT) Q4 Earnings: A Look at Key Metrics - MSN
Signature Healthcare to Enhance Analytics by Leveraging Health Catalyst Ignite™ - PR Newswire
Why Health Catalyst (HCAT) Shares Are Trading Lower Today By Stock Story - Investing.com Canada
Why Health Catalyst (HCAT) Shares Are Trading Lower Today - Yahoo Finance
Health Catalyst stock hits 52-week low at $4.7 amid market challenges By Investing.com - Investing.com South Africa
Health Catalyst stock hits 52-week low at $4.7 amid market challenges - Investing.com
Health Catalyst, Inc. (NASDAQ:HCAT) Q4 2024 Earnings Call Transcript - Insider Monkey
Health Catalyst stock target cut to $10 at BTIG, retains Buy rating By Investing.com - Investing.com South Africa
Health Catalyst (NASDAQ:HCAT) Has Debt But No Earnings; Should You Worry? - Simply Wall St
Health Catalyst Reports Q4 2024 Results with 6% Revenue GrowthNews and Statistics - IndexBox, Inc.
Vaish Associates acts on acquisition of Upfront Healthcare by Health CatalystBar & Bench - Bar & Bench - Indian Legal News
Health Catalyst: Q4 Earnings Snapshot - Thehour.com
Health Catalyst Inc (HCAT) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
Health Catalyst Reports Strong 2024 Financial Performance - TipRanks
Health Catalyst Reports Fourth Quarter and Year End 2024 Results - Markets Insider
Earnings call transcript: Health Catalyst Q4 2024 misses EPS, stock drops - Investing.com
Health Catalyst (HCAT) Misses Q4 Earnings and Revenue Estimates - Yahoo Finance
Health Catalyst Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Health Catalyst’s (NASDAQ:HCAT) Q4 Earnings Results: Revenue In Line With Expectations, Growth To Accelerate Next Year By Stock Story - Investing.com Canada
Health Catalyst, Inc. SEC 10-K Report - TradingView
Health Catalyst’s (NASDAQ:HCAT) Q4 Earnings Results: Revenue In Line With Expectations, Growth To Accelerate Next Year - Yahoo Finance
Health Catalyst’s (NASDAQ:HCAT) Q4 Earnings Results: Revenue In Line With Expectations, Growth To Accelerate Next Year | FinancialContent Business Page - Financial Content
Health Catalyst Announces Board Changes Amid Strong Growth - TipRanks
Health Catalyst (HCAT) Q4 Earnings: What To Expect - The Globe and Mail
Piper Sandler cuts Health Catalyst price target to $8, keeps overweight - MSN
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):